[18F]PBR-111
N/A
Report date: 2025/11/21 17:15:43
NME
Base Information
Drug Name[18F]PBR-111
Drug Alias Name
Classification +[5]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInst For Neurodegenerative Disorders
China Registration ClassN/A
Develop Information
Active CompaniesUniversity Of North Carolina At Chapel Hill
Inactive CompaniesGlaxosmithkline PlcThe Institute For Neurodegenerative Disorders Inc
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A